Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "lidERA Breast Cancer Phase III Adjuvant Study - Giredestrant vs. Physician’s Choice of ET for ER+/HER2- eBC"

345 views
June 14, 2023
Comments 1
Login to view comments. Click here to Login